Results 11 to 20 of about 30,075 (198)

A Case of Severe Ganciclovir-Induced Encephalopathy

open access: yesCase Reports in Neurology, 2013
Background: Ganciclovir, a drug against cytomegalovirus (CMV) infection, is generally well tolerated, but can cause neurotoxicity such as encephalopathy.
Hikaru Sakamoto   +8 more
doaj   +2 more sources

Acute Herpetic Keratitis: What is the Role for Ganciclovir Ophthalmic Gel? [PDF]

open access: yesOphthalmology and Eye Diseases, 2012
Herpes simplex keratitis (HSK) is a major cause of corneal blindness in the world. Following the primary infection, the virus enters into a latent phase.
Afsun Sahin, Pedram Hamrah
doaj   +2 more sources

Repeated intraocular crystallization of ganciclovir in one eye after bilateral intravitreal injections: a case report [PDF]

open access: yesBMC Ophthalmology, 2018
Background Cytomegalovirus (CMV) retinitis is an opportunistic infection that primarily affects immunocompromised individuals. Intravitreal ganciclovir injection monotherapy or in combination with systemic anti-CMV therapy are effective treatments for ...
Lawrence P. L. Iu   +3 more
doaj   +3 more sources

Long Term Therapy of Cytomegalovirus Retinitis with Ganciclovir in a Child with Acquired Immunodeficiency Syndrome

open access: yesCanadian Journal of Infectious Diseases, 1993
Cytomegalovirus retinitis is the most severe ophthalmological complication of patients with acquired immune deficiency syndrome (aids). Ganciclovir must be given continuously to control progression of the disease or relapse typically occurs.
Scott A Halperin, G Robert La Roche
doaj   +2 more sources

Crystallization after intravitreal ganciclovir injection

open access: yesClinical Ophthalmology, 2010
Pitipol Choopong, Nattaporn Tesavibul, Nattawut RodanantDepartment of Ophthalmology, Siriraj Hospital, Mahidol University, Bangkok, ThailandPurpose: To report crystal formation as a complication of intravitreal ganciclovir injection.Patients and methods:
Pitipol Choopong   +2 more
doaj   +1 more source

Topical ganciclovir in the treatment of acute herpetic keratitis

open access: yesClinical Ophthalmology, 2010
Khalid F Tabbara1,2,3, Noorjehan Al Balushi11The Eye Center and The Eye Foundation for Research in Ophthalmology, Riyadh, 2Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia; 3The Wilmer ...
Khalid F Tabbara, Noorjehan Al Balushi
doaj   +1 more source

Ganciclovir use evaluation in kidney transplantation departments

open access: yesJournal of Research in Pharmacy Practice, 2016
Objective: In this study, we evaluated certain aspects of the usage and administration of one lifesaving, high-cost medication, i.e., Ganciclovir for the prevention and treatment of cytomegalovirus (CMV) infection in transplant patients.
Maryam Mozaffar   +2 more
doaj   +2 more sources

Determination of ganciclovir in lung transplant recipients [PDF]

open access: yes, 2023
Charles University Faculty of Pharmacy in Hradec Králové Department of Biochemical Sciences Candidate: Bc. Filip Hrach Supervisor: prof. Ing. Barbora Szotáková, Ph.D. Consultant: doc. Ing. Eva Klapková, Ph.D.
Hrach, Filip
core   +1 more source

A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients [PDF]

open access: yes, 2004
Forty-eight patients who provided 2 consecutive blood samples that tested positive for cytomegalovirus DNA by polymerase chain reaction (PCR) were randomized to receive either full-dose ganciclovir ( 5 mg/kg intravenously [iv] twice daily) or half-dose ...
Potter, M   +31 more
core   +1 more source

Evaluation of the Safety of 2.0% Ganciclovir Eye Drops for Hospital Preparation [PDF]

open access: yes, 2018
The concentration of ganciclovir eye drops for hospital preparation was changed from 0.5% to 2.0% at the Nagasaki University Hospital from March 2015.
佐々木, 均   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy